Company Filing History:
Years Active: 2001-2006
Title: Innovations of Markus Eickmann in Virology
Introduction
Markus Eickmann is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of virology, particularly in the study of the varicella zoster virus (VZV). With a total of 4 patents, Eickmann's work focuses on diagnostic methods that enhance our understanding of viral infections.
Latest Patents
Eickmann's latest patents include the development of immunoreactive proteins and peptides related to the varicella zoster virus. One of his key inventions is the immunoreactive protein VP26, which is described for its diagnostic use. This invention involves immunoreactive peptides homologous to the amino acid positions 12 to 235 of the virus protein VP26. These peptides and their corresponding nucleic acids are crucial for diagnosing infections caused by the virus. Another significant patent pertains to immunoreactive regions of glycoprotein gpII of VZV. This invention focuses on peptides homologous to the amino acid positions 450 to 655 of glycoprotein II, with specific segments identified for their diagnostic utility.
Career Highlights
Markus Eickmann is associated with Dade Behring Marburg GmbH, where he continues to advance research in virology. His work has been instrumental in developing diagnostic tools that aid in the detection of varicella zoster virus infections. Eickmann's innovative approach has positioned him as a key figure in the field.
Collaborations
Eickmann collaborates with notable colleagues such as Dorothee Gicklhorn and Klaus Radsak. Their combined expertise contributes to the ongoing research and development of effective diagnostic methods for viral infections.
Conclusion
Markus Eickmann's contributions to virology, particularly through his patents related to the varicella zoster virus, highlight his role as an influential inventor in the field. His work not only enhances diagnostic capabilities but also furthers our understanding of viral infections.